Navigation Links
Burrill & Company Reacquires Burrill Life Sciences Media Group LLC
Date:12/12/2007

SAN FRANCISCO, Dec. 12 /PRNewswire/ -- Burrill & Company announces today its reacquisition of the Burrill Life Sciences Media Group, LLC (including The Journal of Life Sciences) from Nielsen Business Media, Inc. Terms have not been disclosed.

About Burrill & Company

Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences whose principal activities are in Venture Capital, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions.

Burrill publishes a range of industry intelligence reports and newsletters including: The Journal of Life Sciences, in association with the California Healthcare Institute, The Personalized Medicine Report, The Stem Cell Report, Canadian Biotech News and the Burrill Biotechnology Intelligence Report Quarterly. Its flagship publication is the "State of the Industry." The 22nd edition, entitled Biotech 2008: A Clear Vision to 2020 will be published in January 2008. These publications provide an up-to-date resource for the latest insight, intelligence and information regarding the life sciences industry.


'/>"/>
SOURCE Burrill & Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Biotech Finishes on a High in August, Burrill Report Says
2. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
3. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
4. Cleveland-based Health Care Tech Company Within3 Names New CEO
5. Three Batesville Casket Company Production Facilities Honored for Manufacturing Expertise by National Organizations
6. iCAD to Present at William Blair & Company Small-Cap Growth Stock Conference
7. Elliott Extremely Dissatisfied With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues Company
8. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
9. Neusoft Becomes First Global Growth Company Partner of World Economic Forum
10. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
11. Exponent to Present at the Upcoming Sidoti & Company Investor Forum and William Blair Small-Cap Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... , ... As health professionals work to improve their approach to healthcare, there ... more than filling out a survey; in many cases health professionals and patients are ... care and research on the importance of active engagement with patients and members of ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... 2017 HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, ... three leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has ...
Breaking Medicine Technology: